The forecasted data from 2024 to 2028 for ischaemic heart disease mortality in Canada shows a steady decline among females. In 2023, the mortality rate stood at approximately 12.3 thousand deaths. The year-on-year analysis reveals a gradual decrease, with a 1.8% decline from 2024 to 2025, a subsequent 1.86% decline from 2025 to 2026, a 1.81% reduction from 2026 to 2027, and finally, a 1.93% decrease from 2027 to 2028. The Compounded Annual Growth Rate (CAGR) over this five-year period forecasts an average annual rate of decline of approximately 1.85%.
Future trends to watch for include the impact of advancements in healthcare technology, increased public awareness about heart disease prevention, and potential policy changes that promote healthier lifestyles, which could further influence mortality rates. Continued monitoring of these factors is essential for assessing future trajectories in ischaemic heart disease mortality among females in Canada.
